{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:09:09Z","timestamp":1763035749337,"version":"build-2065373602"},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,12,20]],"date-time":"2002-12-20T00:00:00Z","timestamp":1040342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We describe a patient with cerebellar ataxia of degenerative nature who was administered high\u2010dose piracetam in a single\u2010blind trial. Piracetam was demonstrated to be highly effective on tandem gait and gait ataxia in daily doses of 60 g. We suggest piracetam has a potential anti\u2010ataxic effect in human cerebellar ataxia when used in considerably higher doses than those indicated for other purposes. \u00a9 2002 Movement Disorder Society<\/jats:p>","DOI":"10.1002\/mds.10364","type":"journal-article","created":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T08:10:03Z","timestamp":1048839003000},"page":"457-459","source":"Crossref","is-referenced-by-count":9,"title":["High\u2010dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy"],"prefix":"10.1002","volume":"18","author":[{"given":"Melih","family":"Vural","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"\u00d6zekmek\u00e7i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fclya","family":"Apaydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Altinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,12,20]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"708","article-title":"Effect of buspirone, a serotonergic 5\u2010HT\u20101A agonist in cerebellar ataxia: a pilot study. Preliminary communication","volume":"151","author":"Trouillas P","year":"1995","journal-title":"Rev Neurol"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540340074015"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550180059013"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120426"},{"key":"e_1_2_5_6_2","first-page":"312","article-title":"Buspirone in the treatment of cerebellar ataxia","volume":"127","author":"Svetel M","year":"1999","journal-title":"Srp Arh Celok Lek"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2001.24808"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.61.3.259"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.9.1478"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100047417"},{"key":"e_1_2_5_11_2","first-page":"112","article-title":"D\u00e9riv\u00e9s de L'acide (2\u2010Oxo\u2010Pyrrolidine) ac\u00e9tique","volume":"32","author":"Strubbe JH","year":"1967","journal-title":"Rev Indust Chim Belge"},{"key":"e_1_2_5_12_2","first-page":"247","article-title":"Neurochemical actions of \u201cnootropic drugs","volume":"51","author":"Pepeu G","year":"1990","journal-title":"Adv Neurol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.2.301"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(1997)6 <92::AID-MUS7>3.0.CO;2-E"},{"key":"e_1_2_5_15_2","first-page":"30","article-title":"Effect therapeutique du piracetam dans un cas de myoclonies d'action post\u2010anoxique","volume":"78","author":"Terwinghe G","year":"1978","journal-title":"Acta Neurol Belg"},{"key":"e_1_2_5_16_2","first-page":"3357","article-title":"Myoclonies d'intention et d'action postanoxiques: amelioration par le piracetam","volume":"41","author":"Cremieux C","year":"1979","journal-title":"Nouv Press Med"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/112.3.765"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870080112"},{"key":"e_1_2_5_19_2","first-page":"110","article-title":"Platelet anti\u2010aggregant and rheological properties of piracetam","volume":"43","author":"Moriau M","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110615"},{"key":"e_1_2_5_21_2","first-page":"461","article-title":"Effects de substances stimulantes, sedatives, et hypnotiques sur les taux d'aminoacides cerebrales libres chez le rat","volume":"5","author":"Vial H","year":"1974","journal-title":"J Pharmacol"},{"key":"e_1_2_5_22_2","first-page":"675","article-title":"Piracetam: physiological disposition and mechanism of action","volume":"43","author":"Tacconi MT","year":"1986","journal-title":"Adv Neurol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540290035014"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.10364","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.10364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:36:36Z","timestamp":1760956596000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.10364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,20]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1002\/mds.10364"],"URL":"https:\/\/doi.org\/10.1002\/mds.10364","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"type":"print","value":"0885-3185"},{"type":"electronic","value":"1531-8257"}],"subject":[],"published":{"date-parts":[[2002,12,20]]}}}